Sara Rodríguez-Enríquez Selected Research

casiopeina II-glycine

1/2018	Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
2/2013	Reactive oxygen species are generated by the respiratory complex II--evidence for lack of contribution of the reverse electron flow in complex I.
5/2012	Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
9/2006	Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Rodríguez-Enríquez Research Topics

Disease

47	Neoplasms (Cancer) 02/2022 - 05/2006
9	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 05/2006
9	Hypoxia (Hypoxemia) 01/2019 - 08/2009
7	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2013
6	Carcinoma (Carcinomatosis) 01/2022 - 12/2009
6	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2009
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 08/2015
3	Hypoglycemia (Reactive Hypoglycemia) 10/2017 - 08/2014
2	Carcinogenesis 11/2019 - 08/2009
2	Triple Negative Breast Neoplasms 05/2019 - 12/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Dysbiosis 01/2021
1	Myxoma (Myxomas) 05/2019
1	Chagas Disease (American Trypanosomiasis) 01/2019
1	Medulloblastoma 01/2019
1	Hand-Foot Syndrome 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Ascites 01/2016

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 05/2019 - 12/2009
16	EnzymesIBA 11/2020 - 05/2006
15	Adenosine Triphosphate (ATP)IBA 01/2022 - 09/2006
11	Pharmaceutical PreparationsIBA 12/2020 - 08/2009
9	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 09/2006
8	HexokinaseIBA 01/2016 - 05/2006
6	GlycogenIBA 11/2020 - 11/2010
5	Celecoxib (Celebrex)FDA Link 01/2022 - 01/2018
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020 - 01/2009
5	IsomerasesIBA 11/2020 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2011
5	Succinic Acid (Succinate)IBA 01/2019 - 01/2009
4	casiopeina II-glycineIBA 01/2018 - 09/2006
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2016 - 08/2009
4	Protein Isoforms (Isoforms)IBA 08/2014 - 08/2009
3	Biological ProductsIBA 01/2022 - 02/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 01/2009
3	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 01/2009
3	NADP (NADPH)IBA 11/2020 - 11/2017
3	Adenosine Diphosphate (ADP)IBA 01/2020 - 07/2008
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2009
3	OligomycinsIBA 01/2018 - 09/2006
3	GossypolIBA 06/2017 - 09/2006
3	Messenger RNA (mRNA)IBA 01/2016 - 10/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 06/2014 - 05/2012
3	Oxygen (Dioxygen)IBA 03/2013 - 08/2009
3	alpha-Tocopherol FDA Link 02/2013 - 02/2011
2	VimentinIBA 02/2022 - 05/2019
2	Fibronectins (Fibronectin)IBA 02/2022 - 05/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019 - 11/2011
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 08/2009
2	AntioxidantsIBA 01/2019 - 02/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2009
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 10/2018 - 11/2017
2	TeaIBA 01/2018 - 09/2012
2	Lactate Dehydrogenase 5IBA 01/2018 - 08/2009
2	CytokinesIBA 10/2017 - 06/2014
2	6-phosphogluconic acidIBA 10/2017 - 06/2014
2	Pyruvate KinaseIBA 01/2016 - 08/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 05/2006
2	Phosphates (Orthophosphate)IBA 01/2016 - 06/2014
2	Phosphofructokinase-1 (Phosphofructokinase 1)IBA 05/2014 - 05/2006
2	Glutamine (L-Glutamine)FDA Link 05/2014 - 09/2006
2	Vitamin E FDA LinkGeneric 09/2012 - 11/2011
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2010 - 08/2009
1	Food Additives (Food Additive)IBA 01/2022
1	Carboxylic AcidsIBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	PhosphoglucomutaseIBA 11/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Glutamate DehydrogenaseIBA 01/2020
1	Auranofin (Ridaura)FDA Link 11/2019
1	Protein Kinases (Protein Kinase)IBA 10/2019
1	CateninsIBA 05/2019
1	Matrix Metalloproteinases (MMPs)IBA 05/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2019
1	Ataxia Telangiectasia Mutated ProteinsIBA 03/2019
1	Phosphotransferases (Kinase)IBA 03/2019
1	trypanothioneIBA 01/2019
1	ResveratrolIBA 01/2019
1	CytochromesIBA 01/2019
1	Ifosfamide FDA LinkGeneric 01/2019
1	PeroxidesIBA 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2018
1	Superoxides (Superoxide)IBA 01/2018
1	Aminooxyacetic AcidIBA 01/2017
1	HexosesIBA 01/2016
1	Dihydroxyacetone PhosphateIBA 01/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2016
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016
1	CholesterolIBA 08/2015
1	NAD (NADH)IBA 08/2015

Therapy/Procedure

12	Therapeutics 12/2020 - 01/2009
4	Drug Therapy (Chemotherapy) 11/2019 - 03/2007
1	Immunotherapy 11/2019